Ann Donohue

Ann Donohue

43 year
Health Technology
Consumer Services

Profile

Ann K.
Donohue served as the VP, Chief Financial & Accounting Officer at Selecta Biosciences, Inc. in 2021.
She received her undergraduate and graduate degrees from the Wallace E Carroll School of Management.

Former positions of Ann Donohue

CompaniesPositionEnd
CARTESIAN THERAPEUTICS, INC. Director of Finance/CFO 2021-09-19
See the detail of Ann Donohue's experience

Training of Ann Donohue

Wallace E Carroll School of Management Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ann Donohue's experience

Linked companies

Private companies1
Selecta Biosciences, Inc.
Logo Selecta Biosciences, Inc.

Selecta Biosciences, Inc.

BiotechnologyHealth Technology

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA.

Health Technology

  1. Stock Market
  2. Insiders
  3. Ann Donohue